Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Stayble Therapeutics AB

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 160 Less Arrow 19 More Arrow 41
Earnings before taxes -15,944 Less Arrow -16,389 More Arrow -8,791
EBITDA -16,089 Less Arrow -16,570 More Arrow -8,822
Total assets 14,577 Less Arrow 12,795 More Arrow 31,731
Current assets 10,782 Less Arrow 9,020 More Arrow 27,623
Current liabilities 2,918 Less Arrow 2,015 More Arrow 2,168
Equity capital 11,088 Less Arrow 10,212 More Arrow 28,946
- share capital 2,770 Less Arrow 1,203 More Arrow 1,309
Employees (average) 3 Equal arrow 3 Equal arrow 3

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 76.1% More Arrow 79.8% More Arrow 91.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -108.3% Less Arrow -127.9% More Arrow -27.6%
Current ratio 369.5% More Arrow 447.6% More Arrow 1274.1%
Return on equity (ROE) -143.8% Less Arrow -160.5% More Arrow -30.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Equal arrow 0 More Arrow 1
Chg. No. of employees % 0% Equal arrow 0% More Arrow 50%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.